(Q50751783)

18 March 2018

title

Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. (English)

1 reference

18 March 2018

1 reference

1 reference

Orth SR

1

1 reference

18 March 2018

Nobiling R

series ordinal

2

1 reference

18 March 2018

Bönisch S

series ordinal

3

1 reference

18 March 2018

Ritz E

series ordinal

4

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 March 1996

1 reference

18 March 2018

published in

Kidney International

1 reference

18 March 2018

volume

49

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

868-879

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1038/ki.1996.120

exact match

0 references

cites work

Control of hypertension by verapamil enhances renal damage in a rat remnant kidney model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Verapamil protects against progression of experimental chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Inhibition of human mesangial cell proliferation by calcium channel blockers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Manidipine regulates the transcription of cytokine genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Manidipine affects rPDGF-BB-induced gene transcription of low-density lipoprotein receptors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Is renal protection with calcium antagonists possible?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Single cell analysis of changes in cytosolic calcium induced by vitamin D3 metabolites in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Manidipine inhibits endothelin-1-induced [Ca2+]i signaling but potentiates endothelin's effect on c-fos and c-jun induction in vascular smooth muscle and glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Role of ion flux in the control of c-fos expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Mitogens and melittin stimulate an increase in intracellular free calcium concentration in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Cyclic AMP, calcium and control of cell growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Isolated rat glomerular cells demonstrate L-type Ca(2+)-channel activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Rapid photochemical inactivation of Ca2+-antagonists shows that Ca2+ entry directly activates contraction in frog heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Ca2+ signaling by distinct endothelin peptides in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Calcium release-activated calcium influx in cultured human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Evidence for glomerular actions of epidermal growth factor in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Pharmacokinetics of conventional and slow-release verapamil

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Phorbol esters induce multidrug resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Angiotensin-mediated phosphatidylcholine hydrolysis and protein kinase C activation in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Blockers of voltage-gated K channels inhibit proliferation of cultured brown fat cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Expression and function of P-glycoprotein in human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Antiatherogenic properties of calcium antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Cellular processes in atherogenesis: Potential targets of Ca2+ channel blockers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Mesangial cell behavior in a three-dimensional extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Protective effect of benidipine against the development of glomerular sclerosis in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Phase I and pharmacokinetic study of D-verapamil and doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Stereoisomers in clinical oncology: why it is important to know what the right and left hands are doing.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.120

7 January 2021

Identifiers

DOI

10.1038/KI.1996.120

1 reference

18 March 2018

PubMed ID

8648932

1 reference

18 March 2018